Related Experiment Video
Updated: Jun 19, 2026

07:18
An Electroporation Method to Transform Rickettsia spp. with a Fluorescent Protein-Expressing Shuttle Vector in Tick Cell Lines
Published on: October 11, 2022
STUDIES ON TYPHUS FEVER : X. FURTHER EXPERIMENTS ON ACTIVE IMMUNIZATION AGAINST TYPHUS FEVER WITH KILLED RICKETTSIA
1Department of Bacteriology and Immunology, Harvard University Medical School, Boston.
The Journal of Experimental Medicine
|October 30, 2009
Summary
Vaccines made from Mexican typhus fever Rickettsiae provide resistance in guinea pigs. This vaccine offers complete immunity against moderate infections but limited protection against excessive doses or European strains.
Area of Science:
- Immunology
- Infectious Diseases
- Microbiology
Background:
- Typhus fever is a significant infectious disease.
- Developing effective vaccines is crucial for disease control.
- Previous research explored various methods for Rickettsial vaccine development.
Purpose of the Study:
- To evaluate the efficacy of formalinized Rickettsiae vaccines against typhus fever.
- To determine the level of resistance induced by vaccination in guinea pigs.
- To compare different vaccination and infection routes.
Main Methods:
- Preparation of vaccines using formalinized Rickettsiae from Mexican typhus fever via an X-ray rat method.
- Challenging vaccinated guinea pigs with varying doses of typhus virus.
- Administering vaccines and infectious agents via subcutaneous and intraperitoneal routes.
Main Results:
- Vaccines produced definite resistance in guinea pigs against homologous infection.
- Complete immunity was observed with moderate infectious doses; protection was incomplete with excessive doses.
- Subcutaneous vaccination was as effective as intraperitoneal vaccination.
- Vaccines showed only partial protection against the European (Breinl) strain.
Conclusions:
- Formalinized Mexican typhus Rickettsiae vaccines can induce significant resistance in guinea pigs.
- Vaccine efficacy is dose-dependent and strain-specific.
- Route of administration does not significantly impact vaccine effectiveness for homologous challenge.
More Related Videos
Related Concept Videos
Rocky Mountain Spotted Fever
Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.
Vaccinations
Overview

